Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
Keywords: AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; BDNF; brain-derived neurotrophic factor; Aβ; beta-amyloid peptide; β-CTF; beta-C-terminal fragment; EGCG; epigallocatechin gallate; DFO; desferrioxamine; ERK1/2